Peptide Nanoparticle-Mediated Combinatorial Delivery of Cancer-Related siRNAs for Synergistic Anti-Proliferative Activity in Triple Negative Breast Cancer Cells
Triple negative breast cancer (TNBC) is one of the deadliest types of cancer for women of different age groups. Frequently this cancer does not respond to conservative treatment. Combinatorial RNAi can be suggested as an advanced approach to TNBC therapy. Due to the fact that TNBC cells overexpress...
Main Authors: | Anna Egorova, Ivan Pyankov, Marianna Maretina, Vladislav Baranov, Anton Kiselev |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/10/957 |
Similar Items
-
Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes
by: Anna A. Egorova, et al.
Published: (2019-06-01) -
Targeting cell cycle proteins in breast cancer cells with siRNA by using lipid-substituted polyethylenimines
by: Manoj eParmar, et al.
Published: (2015-02-01) -
AQP3 and AQP5—Potential Regulators of Redox Status in Breast Cancer
by: Lidija Milković, et al.
Published: (2021-04-01) -
Advances in siRNA therapeutics and synergistic effect on siRNA activity using emerging dual ribose modifications
by: Sumit Gangopadhyay, et al.
Published: (2022-12-01) -
CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead
by: Eldad Zacksenhaus, et al.
Published: (2018-07-01)